Same Indication

Imatinib vs Sitagliptin

Imatinib vs Sitagliptin: Overview

This comparison examines the pharmacological differences between Imatinib and Sitagliptin.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Sitagliptin: DPP-4 inhibitor increasing incretin levels.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Sitagliptin — 12.4 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Sitagliptin — C16H15F6N5O.

Molecular Weight: Imatinib — 493.6030 g/mol; Sitagliptin — 407.3140 g/mol.

Type: Imatinib — Small molecule; Sitagliptin — Small molecule.